Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface malignancies but it is an extensive procedure predisposing to major complications. Among them renal toxicity was reported. Severe renal insu...

Full description

Saved in:
Bibliographic Details
Published inJournal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) Vol. 3; no. 4; pp. 158 - 161
Main Authors Bartos, Adrian, Breazu, Caius, Bartos, Dana, Ciobanu, Lidia, Mitre, Calin
Format Journal Article
LanguageEnglish
Published Poland De Gruyter Open 01.10.2017
Sciendo
Subjects
acute renal failure
Case Report
cytoreductive surgery
diabetes mellitus
hyperthermic intraperitoneal chemotherapy
diabetes mellitus
acute renal failure
hyperthermic intraperitoneal chemotherapy
cytoreductive surgery
Online AccessGet full text

Cover

More Information
Summary:Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves the prognosis in selected patients with peritoneal surface malignancies but it is an extensive procedure predisposing to major complications. Among them renal toxicity was reported. Severe renal insufficiency is considered a contraindication for this complex procedure. We present a patient with diabetic nephropathy with renal insufficiency KDOQI 3 and peritoneal metastasis from sigmoid adenocarcinoma with a good clinical outcome after CRS with HIPEC, highlighting the anesthetic precautions considered for this particular clinical case.
ISSN:2393-1809
2393-1817
2393-1817
DOI:10.1515/jccm-2017-0027